Media Thread, page-10945

A few takeaways from the Proactive clip ...

First ... Thank you @GMT2 for posting this video. Always great to see and hear directly.

Second ... @col75 you are absolutely correct. LC will certainly now have plenty of BP attention at this next event.

Third ... sorry @Single I just can't agree with you this one. Any positive publicity is good publicity. One of our 'issues'
recently has been public perception, or lack of understanding, of what IMU are trying to achieve. All these interviews help.

Fourth ... Think about this ... this is amazing ... up to this point, the MAST trial has only had TWO (yes, 2) patients with
Bile Duct cancer. Note: both have very positive 'signals'. They have seen one CR continuing after a year and one SD after
just 6 months. I don't need to explain that they are batting at 100% here. If this is replicated in a larger cohort, and they
just announced that they have received this 'go head' to expand, in he most significant way, then hold onto your hat.
This could move very quickly. These two patients are only dosed at low to mid levels remember.
We are also now permitted to have 'rolling reviews' with the FDA.

As Leslie mentioned in the interview, we clearly have "FDA attention" now, and in the best way possible.
If we have FDA attention we will also garner PB attention. Things are moving very quickly. I am not game to
predict time-frames, or when we will see future 'data cuts', but announcements could come at any time. Anytime!

IMU will recruit both here (Oz) and in the US, so this will further increase the speed of enrollment in the BD trial.
We already know we have great interest from many oncologists.

Watch this space. Just don't blink.

Opinions only, as always.